Brimonidine Tartrate And Timolol Maleate Ophthalmic Solution Solution/ Drops
Product Images NDC 73043-029

6 FDA label images from Devatis Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate And Timolol Maleate Ophthalmic Solution (NDC 73043-029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Devatis Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brimonidine-structure (Brimonidine Structure)

Brimonidine-structure (Brimonidine Structure)
Chemical structure diagram showing two molecular structures likely representing the active ingredients brimonidine tartrate and timolol maleate in Brimonidine Tartrate and Timolol maleate Ophthalmic Solution. The diagram displays ring systems and functional groups such as NH, Br, COOH, and OH groups.*
FDA Label Image

Brimonidine-timolol-spl-10-ml-bottle-label (Brimonidine Timolol Spl 10 mL Bottle Label)

Brimonidine-timolol-spl-10-ml-bottle-label (Brimonidine Timolol Spl 10 mL Bottle Label)
Label for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution 0.2%/0.5%, 10 mL sterile drops. Contains brimonidine tartrate 0.2% and timolol 0.5%, with preservative benzalkonium chloride 0.005%. Manufactured in Turkey and distributed by Devatis Inc., San Clemente, CA. Rx only.*
FDA Label Image

Brimonidine-timolol-spl-10-ml-carton-label (Brimonidine Timolol Spl 10 mL Carton Label)

Brimonidine-timolol-spl-10-ml-carton-label (Brimonidine Timolol Spl 10 mL Carton Label)
Packaging label for Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%, an eye drop solution in a 10 mL bottle. The label states the product is sterile, for eye use only, and prescription only. Distributed by Devatis Inc., San Clemente, CA, the product is made in Turkey. The label includes NDC 73043-029-02 and lists active ingredients, preservative, and inactives.*
FDA Label Image

Brimonidine-timolol-spl-5-ml-bottle-label (Brimonidine Timolol Spl 5 mL Bottle Label)

Brimonidine-timolol-spl-5-ml-bottle-label (Brimonidine Timolol Spl 5 mL Bottle Label)
Label for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution 0.2%/0.5%, a sterile eye drop solution in a 5 mL bottle. Distributed by Devatis Inc., San Clemente, CA. The label lists active ingredients with strengths and includes storage instructions and preservative information.*
FDA Label Image

Brimonidine-timolol-spl-5-ml-carton-label (Brimonidine Timolol Spl 5 mL Carton Label)

Brimonidine-timolol-spl-5-ml-carton-label (Brimonidine Timolol Spl 5 mL Carton Label)
Label for Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5% in a 5 mL bottle. The label includes active ingredients, preservatives, inactives, usual dosage instructions, and storage conditions. It states the product is for eye use only, Rx only, sterile, made in Turkey, and distributed by Devatis Inc., San Clemente, CA. The label also features the Devatis logo and barcodes.*
FDA Label Image

Timolol-structure (Timolol Structure)

Timolol-structure (Timolol Structure)
Chemical structure diagram showing the molecular structure of Brimonidine Tartrate, the active ingredient in Brimonidine Tartrate and Timolol maleate Ophthalmic Solution. The structure illustrates the arrangement of atoms and chemical bonds in the Brimonidine Tartrate molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.